Jerome Gangitano - InVivo Therapeutics VP Operations

Summary

NVIVDelisted Stock

USD 1.38 0.07 5.34%

Insider

Jerome Gangitano is VP Operations of InVivo Therapeutics Holdings

Phone	617 863 5500
Web	https://www.invivotherapeutics.com

InVivo Therapeutics Management Efficiency

The company has return on total asset (ROA) of (0.5371) % which means that it has lost $0.5371 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.9811) %, meaning that it created substantial loss on money invested by shareholders. InVivo Therapeutics' management efficiency ratios could be used to measure how well InVivo Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities.

Compare InVivo Therapeutics to Peers

InVivo Therapeutics Holdings currently holds 949 K in liabilities with Debt to Equity (D/E) ratio of 0.09, which may suggest the company is not taking enough advantage from borrowing. InVivo Therapeutics has a current ratio of 5.53, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about InVivo Therapeutics' use of debt, we should always consider it together with its cash and equity.

Similar Executives

Showing other executives			INSIDER Age
	MD FACP	NextCure	71
	Hing Wong	HCW Biologics	70
	MaryJane Rafii	Kiora Pharmaceuticals	N/A
	MD MBA	Kiora Pharmaceuticals	50
	Nicole White	Assembly Biosciences	N/A
	Chester III	Revelation Biosciences	44
	Adam Zlotnick	Assembly Biosciences	N/A
	Alexander Zurcher	Molecular Partners AG	49
	Jo PalmerPhillips	Eliem Therapeutics	N/A
	Lieping MD	NextCure	67
	CPA CPA	NextCure	61
	, MBA	Molecular Partners AG	51
	Rex CFA	Anebulo Pharmaceuticals	64
	MD MBA	Rezolute	N/A
	Tharaknath Rao	Assembly Biosciences	N/A
	Brian Strem	Kiora Pharmaceuticals	44
	Carol Odle	Revelation Biosciences	N/A
	Dr IV	Assembly Biosciences	52
	Michele Anderson	Assembly Biosciences	N/A
	Melissa Tosca	Kiora Pharmaceuticals	N/A
	Ian Critchley	Spero Therapeutics	N/A

InVivo Therapeutics Holdings Corp., a research and clinical-stage biomaterials and biotechnology company, engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries . The company was incorporated in 2003 and is headquartered in Cambridge, Massachusetts. Invivo Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 7 people. InVivo Therapeutics Holdings (NVIV) is traded on NASDAQ Exchange in USA and employs 6 people.

Management Performance

	Return On Equity	-0.98
	Return On Asset	-0.54

InVivo Therapeutics Leadership Team

Elected by the shareholders, the InVivo Therapeutics' board of directors comprises two types of representatives: InVivo Therapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of InVivo. The board's role is to monitor InVivo Therapeutics' management team and ensure that shareholders' interests are well served. InVivo Therapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, InVivo Therapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.

	Jerome Gangitano, VP Operations
	Joseph MD, CoFounder
	Richard Christopher, CFO, Treasurer
	Dr Langer, CoFounder Board
	MD FACP, Consultant
	Heather JD, Chief Counsel
	Richard MD, CEO and Presidentident
	Richard Toselli, Chief Medical Officer
	Joseph Vacanti, CoFounder

InVivo Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is InVivo Therapeutics a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

	Return On Equity	-0.98
	Return On Asset	-0.54
	Current Valuation	(7.59 M)
	Shares Outstanding	3.11 M
	Shares Owned By Insiders	0.02 %
	Shares Owned By Institutions	3.44 %
	Number Of Shares Shorted	17.63 K
	Price To Earning	(1.90) X
	Price To Book	0.1 X
	EBITDA	(9.8 M)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Other Consideration for investing in InVivo Stock

If you are still planning to invest in InVivo Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the InVivo Therapeutics' history and understand the potential risks before investing.

	Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
	Risk-Return Analysis View associations between returns expected from investment and the risk you assume
	Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators
	Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
	Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges
	ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
	Bonds Directory Find actively traded corporate debentures issued by US companies
	Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities
	Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC